BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31008436)

  • 1. Majority of
    Middha S; Yaeger R; Shia J; Stadler ZK; King S; Guercio S; Paroder V; Bates DDB; Rana S; Diaz LA; Saltz L; Segal N; Ladanyi M; Zehir A; Hechtman JF
    JCO Precis Oncol; 2019; 3():. PubMed ID: 31008436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B2M and JAK1/2-mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy.
    Zhang C; Li D; Xiao B; Zhou C; Jiang W; Tang J; Li Y; Zhang R; Han K; Hou Z; Zhang L; Sui Q; Liao L; Pan Z; Zhang X; Ding P
    J Immunother; 2022 May; 45(4):187-193. PubMed ID: 35343934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
    Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
    Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
    Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
    Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint blockade resistance-related B2M hotspot mutations in microsatellite-unstable colorectal carcinoma.
    Yeon Yeon S; Jung SH; Jo YS; Choi EJ; Kim MS; Chung YJ; Lee SH
    Pathol Res Pract; 2019 Jan; 215(1):209-214. PubMed ID: 30503610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic analysis of the beta-2-microglobulin gene in microsatellite instable colorectal cancer.
    Snahnicanova Z; Kasubova I; Kalman M; Grendar M; Mikolajcik P; Gabonova E; Laca L; Caprnda M; Rodrigo L; Ciccocioppo R; Kruzliak P; Plank L; Lasabova Z
    Clin Exp Med; 2020 Feb; 20(1):87-95. PubMed ID: 31853669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational profiling of colorectal cancers with microsatellite instability.
    Lin EI; Tseng LH; Gocke CD; Reil S; Le DT; Azad NS; Eshleman JR
    Oncotarget; 2015 Dec; 6(39):42334-44. PubMed ID: 26517354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers.
    Liu F; Zhong F; Wu H; Che K; Shi J; Wu N; Fu Y; Wang Y; Hu J; Qian X; Fan X; Wang W; Wei J
    Oncologist; 2023 Mar; 28(3):e136-e144. PubMed ID: 36724040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
    Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
    J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune environment in serrated lesions of the colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression.
    Acosta-Gonzalez G; Ouseph M; Lombardo K; Lu S; Glickman J; Resnick MB
    Hum Pathol; 2019 Jan; 83():115-123. PubMed ID: 30172913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers.
    Kim JH; Park HE; Cho NY; Lee HS; Kang GH
    Br J Cancer; 2016 Aug; 115(4):490-6. PubMed ID: 27404452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of ARID1A mutations on colorectal cancer and associations with PD-L1 expression by stromal cells.
    Kamori T; Oki E; Shimada Y; Hu Q; Hisamatsu Y; Ando K; Shimokawa M; Wakai T; Oda Y; Mori M
    Cancer Rep (Hoboken); 2022 Jan; 5(1):e1420. PubMed ID: 34042312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers.
    Kim JH; Seo MK; Lee JA; Yoo SY; Oh HJ; Kang H; Cho NY; Bae JM; Kang GH; Kim S
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High numbers of PDCD1 (PD-1)-positive T cells and
    Janikovits J; Müller M; Krzykalla J; Körner S; Echterdiek F; Lahrmann B; Grabe N; Schneider M; Benner A; Doeberitz MVK; Kloor M
    Oncoimmunology; 2018; 7(2):e1390640. PubMed ID: 29308317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data.
    Middha S; Zhang L; Nafa K; Jayakumaran G; Wong D; Kim HR; Sadowska J; Berger MF; Delair DF; Shia J; Stadler Z; Klimstra DS; Ladanyi M; Zehir A; Hechtman JF
    JCO Precis Oncol; 2017; 2017():. PubMed ID: 30211344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Antigenicity and a Pre-Existing Adaptive Immune Response in Advanced BRAF Mutant Colorectal Cancers.
    Bolzacchini E; Libera L; Church SE; Sahnane N; Bombelli R; Digiacomo N; Giordano M; Petracco G; Sessa F; Capella C; Furlan D
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased CD8 Tumor Infiltrating Lymphocytes in Colorectal Cancer Microenvironment Supports an Adaptive Immune Resistance Mechanism of PD-L1 Expression.
    Sudoyo AW; Kurniawan AN; Kusumo GD; Putra TP; Rexana FA; Yunus M; Budiyati AD; Kurniawan D; Utama A; Utomo AR
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3421-3427. PubMed ID: 31759368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ.
    Kikuchi T; Mimura K; Okayama H; Nakayama Y; Saito K; Yamada L; Endo E; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Kono K
    Oncol Lett; 2019 Dec; 18(6):5977-5985. PubMed ID: 31788072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma.
    Park HE; Kim JH; Cho NY; Lee HS; Kang GH
    Virchows Arch; 2017 Sep; 471(3):329-336. PubMed ID: 28597080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.